TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on December 9

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Biovie Inc.
Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on December 9

BioVie Inc. will host an investor webinar on December 9, 2025, featuring CEO Cuong Do discussing their drug candidates bezisterim and BIV201 for neurological diseases and liver cirrhosis, highlighting clinical progress and potential market opportunities.

Insights
BIVI   positive

Company is advancing multiple late-stage clinical programs with promising drug candidates targeting significant medical conditions, showing strong safety data and potential for market expansion